Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2005
03/10/2005US20050054588 Methods and compositions for the treatment of asthma and related disorders
03/10/2005US20050054587 Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseases
03/10/2005US20050054586 Using cloricromene , or hydrochloride thereof
03/10/2005US20050054585 Using saccharide; bone disorders
03/10/2005US20050054584 Reducing weight and damage cuased by diabetes; antidiabetic agents
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
03/10/2005US20050054577 Irritable bowel disorders; controlling permeability of intestine tissue ; anticholinergic agent
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor
03/10/2005US20050054574 Using calcium channel blockers
03/10/2005US20050054568 Angiogenesis-modulating compositions and uses
03/10/2005US20050054561 Abuse-resistant amphetamine compounds
03/10/2005US20050054557 Osteoporosis therapy; concurrent administering by mouth
03/10/2005US20050054108 Yeast membrane protein expression system and its application in drug screening
03/10/2005US20050054095 For treatment and/or prevention of inflammation and autoimmune disease; vaccines
03/10/2005US20050054091 Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
03/10/2005US20050054090 MHC class II antigen-presenting systems and methods for activating CD4cells
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050054018 Using cell cycle checkpoint activation modulators to prevent and treat cell proliferative disorders
03/10/2005US20050054008 Identifying modulators which control migration of nuclear receptor from nucleus to non-nuclear cell target; screening for agent which prevent and treat cell proliferative disorders
03/10/2005US20050053992 Methods for screening cellular proliferation using isotope labels
03/10/2005US20050053977 Methods for treating lentivirus infections
03/10/2005US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
03/10/2005US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection
03/10/2005US20050053696 Stable and bioavailable iron fortified beverages
03/10/2005US20050053682 Oral treatment for anorectal conditions
03/10/2005US20050053681 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds
03/10/2005US20050053678 Methods and compositions for betel nut chewing gum
03/10/2005US20050053676 Powdered composition for use as laxative
03/10/2005US20050053675 Method of making, and the use of cytotoxic agents containing elemental selenium
03/10/2005US20050053674 Pharmaceutical composition and method for retardation of the progression of atherosclerosis
03/10/2005US20050053673 Nutraceutical formulation for healing human bone due to accidental fracture or surgical replacement or grafting, containing lysine, proline, ascorbic acid, copper, and vitamin B6
03/10/2005US20050053670 use of an organic lubricant and no alkali metal salts of metaphosphates in an effective amount into the birth canal of the woman during delivery
03/10/2005US20050053668 allows targeted delivery of bioactive factors to bone using nanocapsules having an amphipathic surface made of polyethylene glycol-modified phospholipid
03/10/2005US20050053665 absorption of nicotine into and/or adsorption of nicotine onto cellulose of non-seed organism origin such as algae, bacteria and fungi, to stabilize nicotine; for providing a sense of smoking satisfaction without smoking
03/10/2005US20050053664 Reduced toxicity; enhance efficiency; side effect reduction; anticarcinogenic agent; administering to a cancer patient admixture having (((1,4)-linked beta -D-mannopyranose)17-((1,6)-linked- beta -D-galactopyranose)10)12) and a chemotherapeutic agent
03/10/2005US20050053661 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type II diabetes mellitus
03/10/2005US20050053660 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
03/10/2005US20050053659 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
03/10/2005US20050053658 Extended release systems for macrolide antibiotics
03/10/2005US20050053656 Compositions and methods for treating pain
03/10/2005US20050053655 microcapsules containing an antiulcer agent or antacid within a polymeric matrix formed by a hydrogel, both separated from each other by a surfactant such as lecithin
03/10/2005US20050053654 able to disintegrate in buccal cavity upon contact with saliva by formation of an easy-to-swallow suspension, in less than 60 seconds, containing fexofenadine or its salt and a binder, in the form of a coated granule, and excipients such as disintegrating agent, a soluble diluent, and a lubricant
03/10/2005US20050053652 Pharmaceutical composition containing citalopram
03/10/2005US20050053647 Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction
03/10/2005US20050053641 Method of treating irritable bowel syndrome
03/10/2005US20050053640 Mixing protein (soy) or hydrocolloid (carboxyl methylcellulose) in water, adding glycerol, heating the mixture create a film solution and adding an organic acid (malic acid)
03/10/2005US20050053637 Designing an individual's skin care protocol based on a biomarker profile determined from sampled skin; skin condition such as atopic, psoriasis, seborrhea, ichtiotic, acne, xerotic, irritation, allergy
03/10/2005US20050053631 Use of a fatty acid synthase (FAS) inhibitor; cosmetics; FAS inhibitors such as triclosan, cerulenin, EGCG (epigallocatechol gallate), alpha-methylene-gamma-butyrolactone; acne
03/10/2005US20050053625 Method of treating viral infections
03/10/2005US20050053619 Nose sprays for relief of congestion and pain using vegetable oils, menthol, benzoin, thymol and sodium bicarbonate in water
03/10/2005US20050053612 Nucleotide regulation of immune responses
03/10/2005US20050053611 Antibody directed enzyme prodrug therapy and a kit with antihumanseminal plasma protein single chain antibodies and prodrugs
03/10/2005US20050053595 White cream bacteriostats, fungicide as vehicle for drug; receptivity
03/10/2005US20050053583 Method of inhibiting prion protein
03/10/2005US20050053581 Which effect p53 binding/inactivation; enhances efficacy of such viruses for treating cancer; liposomes
03/10/2005US20050053578 For use as wound closure adhesives
03/10/2005US20050053577 Linking low molecular weight drugs containing a carboxylic acid group and an amine, thiol, alcohol or phenol, which is released when hydrolysis occurs; for treatment of cancer
03/10/2005US20050053576 Glycosaminoglycan-polycation complex crosslinked with polyfunctional crosslinking agent and process for producing the same
03/10/2005US20050053572 Does not cause any side effects and has superior hair growth-promoting effects
03/10/2005US20050053560 Use of a composition containing extracts of Vitis vinifera and lycopersicum for protecting the skin
03/10/2005US20050053559 Carotenoid composition and method for protecting skin
03/10/2005US20050053558 Lemon balm, passion flower, and valerian; and the hormone melatonin
03/10/2005US20050053557 Administering a lignan comprising 4-(phenyl)-furo/3*,4*:6,7/-naphtho/2,3-d/-1,3-dioxole derivative or plant extract
03/10/2005US20050053553 Combined doses of formoterol and fluticasone
03/10/2005US20050052058 Folding table and bench system
03/10/2005US20050051922 Dosage form comprising: controlled release core of an antihyperglycemic drug and an excipient.seal coat applied to the controlled release core; may also include immediate release thiazolidinedione coating over the seal coat
03/10/2005US20050051483 forskolin, isoforskolin or 7-deacetylforskolin complexing/solubilizing with cyclodextrin agent; ophthamology
03/10/2005US20050051103 Composition with multiple uses for poultry
03/10/2005CA2824106A1 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005CA2741404A1 Antioxidant sensor, methods and compositions
03/10/2005CA2564227A1 Novel drug compositions and dosage forms of topiramate
03/10/2005CA2539953A1 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
03/10/2005CA2539032A1 Glucopyranosyloxy-pirazoles, drugs containing said compounds the use and production method thereof
03/10/2005CA2537610A1 Pharmaceutical composition, method of manufacturing and therapeutic use thereof
03/10/2005CA2537535A1 Novel medical use of selective cb1-receptor antagonists
03/10/2005CA2537487A1 Piperazine substituted compounds used as calcium channel blockers
03/10/2005CA2537459A1 Formulation of a mixture of free-b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
03/10/2005CA2537413A1 Sustained release dosage forms of ziprasidone
03/10/2005CA2537396A1 Antimicrobial acrylic polymer
03/10/2005CA2537364A1 Imidazo[1,5-a]pyridine or imidazo[1,5-a]piperidine derivatives and their use for the preparation of medicament against 5-ht2a receptor-related disorders
03/10/2005CA2537349A1 The claimed invention relates to novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-ht2a receptor-related disorders
03/10/2005CA2537185A1 Inhibitors of phosphodiesterase type-iv
03/10/2005CA2537184A1 Gene therapy for skin disorders using needleless syringes
03/10/2005CA2537182A1 Compositions useful for treating gastrointestinal motility disorders
03/10/2005CA2537180A1 Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
03/10/2005CA2537178A1 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer
03/10/2005CA2537170A1 Acid containing oxaliplatin formulations
03/10/2005CA2537141A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
03/10/2005CA2537132A1 Amorphous valganciclovir hydrochloride
03/10/2005CA2537119A1 Ophthalmic compositions for treating ocular hypertension
03/10/2005CA2537115A1 Methods for the early diagnosis of ovarian cancer
03/10/2005CA2537099A1 Modulation of .beta.-catenin/tcf activated transcription
03/10/2005CA2537093A1 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005CA2537090A1 Use of 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
03/10/2005CA2537088A1 Using selective antagonists of persistent sodium current to treat neurological disorders and pain
03/10/2005CA2537060A1 Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
03/10/2005CA2537057A1 Cancer treatment with epothilones
03/10/2005CA2536955A1 Silver dihydrogen citrate compositions comprising a second antimicrobial agent
03/10/2005CA2536912A1 Combination therapy for the treatment of ocular neovascular disorders
1 ... 4760 4761 4762 4763 4764 4765 4766 4767 4768 4769 4770 4771 4772 4773 4774 4775 4776 4777 4778 4779 4780 ... 7860